iopamidol has been researched along with Arteriosclerosis Obliterans in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoli, JM; Chagnaud, C; Delannoy, L; Gaubert, JY; Haddad, D; Kasbarian, M; Moulin, G | 1 |
1 trial(s) available for iopamidol and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
Topics: Adult; Aortic Aneurysm, Abdominal; Arteriosclerosis Obliterans; Contrast Media; Double-Blind Method; Female; Humans; Iopamidol; Kidney Diseases; Male; Neoplasms; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole-Body Irradiation | 1992 |